Bone Metastases in Follicular Carcinoma of Thyroid

  • Pooja Pal
  • Bikramjit Singh
  • Shubhada Kane
  • Pankaj Chaturvedi
Original Article


Though the association between follicular carcinoma and bone metastasis is well established, the site-wise distribution is not known. One hundred seventy-three patients of follicular carcinoma presenting between 2003 and 2011 were selected from 1093 patients of follicular lesions presenting at a single institution. Of these, 59 (34%) with bone metastasis were included in the study. Fifty of the 59 patients (84.7%) had metastasis at presentation, while 9 developed bone metastasis during follow-up. Sixty-one percent had solitary metastasis, 15 (25.4%) had multiple bone involvement, while 8 patients (13.6%) had synchronous lung metastasis. Overall, the spine was the commonest site of bone metastases, seen in 20 patients (33.9%), followed by the pelvis, skull, long bones and sternum. Bone metastasis is a known phenomenon in follicular carcinoma. The spine is the commonest site followed by the pelvis.


Adenocarcinoma Follicular Thyroid neoplasm Bone neoplasm 


Compliance with Ethical Standards

Conflict of interest

All authors declares that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study. Being a retrospective study, for this type of study formal consent is not required.


  1. 1.
    Ramadan S, Ugas MA, Berwick RJ, Notay M, Cho H, Jerjes W, Giannoudis PV (2012) Spinal metastasis in thyroid cancer. Head Neck Oncol 4:39CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Eustacia-Rutten CF, Romijri JA, Guijt MJ, Vielvoye GJ, van den Berg R, Corssmit EPM, Pereira AM, Smit JWA (2003) Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab 88:3184–3189CrossRefGoogle Scholar
  3. 3.
    Schlumberger M, Tubiana JP, Fragu P, Lumbroso J, Caillou B, Parmentier C (1986) Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 63:960–967CrossRefPubMedGoogle Scholar
  4. 4.
    Satcher RL, Lin P, Harun N, Feng L, Moon BS, Lewis VO (2012) Surgical management of appendicular skeletal metastases in thyroid carcinoma. Int J Surg Oncol 2012:417086. doi: 10.1155/2012/417086 PubMedPubMedCentralGoogle Scholar
  5. 5.
    Lang BH, Wong KP, Cheung CY, Wan KY, Lo CY (2013) Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis. Ann Surg Oncol 20:1329–1335CrossRefPubMedGoogle Scholar
  6. 6.
    Lang BH, Lo CY, Chan WF, Lam KY, Wan KY (2007) Prognostic factors in papillary and follicular thyroid carcinoma: implications for cancer staging. Ann Surg Oncol 14:730–738CrossRefPubMedGoogle Scholar
  7. 7.
    Sobrinho SM, Asa SL, Kroll TG, Nikifarav Y, DeLellis R, Farid P, Kitamura Y, Noguchi SU, Eng C, Harach HR (2004) Follicular carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU (eds) World Health Organization classification of tumors of endocrine organs. IARC Press, Lyon Eng C, pp 67–72Google Scholar
  8. 8.
    Tickoo SK, Pittas AG, Adler M, Fazzaari M, Larson SM, Robbins RJ, Rosai J (2000) Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates. Arch Pathol Lab Med 124:1440–1447PubMedGoogle Scholar
  9. 9.
    Rao RS, Parikh HK, Deshmane VH, Parikh DM, Shrikhande SS, Havaldar R (1996) Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases. Head Neck 18:118–124CrossRefPubMedGoogle Scholar
  10. 10.
    Lin X, Zhu B, Liu Y, Silverman JF (2010) Follicular thyroid carcinoma invades venous rather than lymphatic vessels. Diagn Pathol 5:8CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Muresan MM, Oliver P, Leclere J, Sirveaux F, Brunaud L, Klein M, Zarnegar R, Weryha G (2008) Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer 15(1):37–49CrossRefPubMedGoogle Scholar
  12. 12.
    Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375–379CrossRefPubMedGoogle Scholar
  13. 13.
    Nixon IJ, Whitcher MM, Palmer FL, Tuttle RM, Shaha AR, Shah JP, Patel SG, Ganly I (2012) The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland. Thyroid 22(9):884–889CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Pittas AG, Adler M, Fazzari M (2000) Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variable in one hundred forty-six patients. Thyroid 10(3):261–268CrossRefPubMedGoogle Scholar
  15. 15.
    Kushchayev S, Kushchayev Y, Theodore N, Preul MC, Clark OH (2010) Percutaneous vertebroplasty for thyroid cancer metastases to the spine. Thyroid 20:555–560CrossRefPubMedGoogle Scholar
  16. 16.
    Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91(8):2892–2899CrossRefPubMedGoogle Scholar
  17. 17.
    Lee J, Soh EY (2010) Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors. Ann Surg 251:114–119CrossRefPubMedGoogle Scholar
  18. 18.
    Lang BH, Lo CY, Chan WF, Lam KY, Wan KY (2007) Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg 245:366–378CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Orita Y, Sugitani I, Matsuura M (2010) Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. Surgery 147:424–431CrossRefPubMedGoogle Scholar
  20. 20.
    Orita Y, Sugitani I, Toda K, Manabe J, Fujimoto Y (2011) Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma. Thyroid 21:31–35CrossRefPubMedGoogle Scholar
  21. 21.
    Nagamine Y, Suzuki J, Katakura R, Yoshimoto T, Matoba N, Takaya K (1985) Skull metastasis of thyroid carcinoma, study of 12 cases. J Neurosurg 63:526–531CrossRefPubMedGoogle Scholar

Copyright information

© Association of Otolaryngologists of India 2017

Authors and Affiliations

  • Pooja Pal
    • 1
    • 2
  • Bikramjit Singh
    • 1
    • 3
  • Shubhada Kane
    • 4
  • Pankaj Chaturvedi
    • 1
  1. 1.Head and Neck ServicesTata Memorial HospitalMumbaiIndia
  2. 2.Department of Otolaryngology and Head Neck SurgerySGRD HospitalAmritsarIndia
  3. 3.Department of Surgical OncologyGovernment Medical CollegeAmritsarIndia
  4. 4.Department of PathologyTata Memorial HospitalMumbaiIndia

Personalised recommendations